One-Liner
A consumer tool generating ready-to-file ACA Section 2719 external review submissions for patients whose insurance claims have been denied.
AI Thinking Process
Impossibility Negation engine fired: 'You can't generate plain-language patient appeals for ACA External Review at scale' — was true two years ago. Now possible with large-context AI reading denial letters, 100-page coverage documents, and relevant medical guidelines.
Patient ACA External Review Submission Builder: consumer tool reading denial letter + plan coverage doc + medical guidelines, drafting IRO submission packet. ACA Section 2719 gives federal right to binding external review. 40% historical reversal rate. Per-event pricing $99-249 + success fee.
WHO: US patient or parent with >$500 denied insurance claim. CURRENT: accept denial (~80% case rate) or hire patient advocate at $300-500/hour. WHY-SURPRISED: federal right exists, IRO process documented, success rates ~40%, but no consumer self-serve tool prepares the submission. G053 pattern confirmed.
Memory scan: Brella, Health Advocate (broker-paid), Resolve (medical billing, not appeals), Solace ($14M, advocates). No consumer AI ACA External Review tool recalled. G016 memory blindness flag applied.
Survived Pass 1 at 45% conviction. Biggest worry: Solace or another patient-advocate marketplace launches self-serve AI external review feature within 18 months.
Counterforce Health: free AI appeal generator, NIH + UPenn funded, 70% success rate, explicit external review panel support, featured in CBS Philadelphia, NBC News, Axios, US News. Claimable Inc.: $50/appeal, 80% success rate, customized appeal letters with clinical research. Solace: human advocates including explicit IRO submission support. Three separate offerings cover free, transactional, and premium tiers.
KILLED IN DEEPENING: Counterforce Health (free, NIH-funded, national media) and Claimable Inc. ($50, 80% success) occupy exactly the proposed product and pricing spaces. The 'empty consumer-regulatory category' thesis was refuted. No brand-establishment window remains.
Kill Reason
Counterforce Health (NIH and University of Pennsylvania funded, 70% success rate, free to consumers, national media coverage) and Claimable Inc. ($50 per appeal, 80% success rate) already occupy the exact product and pricing spaces proposed. Solace Health provides the premium human-advocate alternative. The 'empty category' thesis was refuted by a 30-second web search.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Historical duplicate of 'No Surprises Act Consumer Medical Bill Dispute Platform' from session 20260413-1538-crossdomain (4 days prior). Same federal IDR regulation, same consumer patient buyer, same core dispute-workflow value proposition.
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.